Here is which batch is withdrawn and which drug it is
High blood pressure is a disorder that affects a large number of Italians. It manifests itself as a headache in the morning, ringing in the ears, a nosebleed (epistaxis), a feeling of dizziness and disturbed vision. To avoid the progression of the problem with serious consequences for health (stroke or heart attack), the attending physician usually recommends the regular intake of a tablet that can control blood pressure. For some days, however, a well-known drug for the management of arterial hypertension has been withdrawn from the market: Atenolol-Mepha®produced and distributed by the Swiss company Mepha Pharma AG. Also to read Food alert, the Ministry of Health raises the alarm for salmonella risk chocolate eggs
Recalled a well-known drug for high blood pressure: the causes
With reference to one lot in particular, it seems that the medicine contains a slightly lower quantity of the active ingredient and consequently has a mild effect on the body. The well-known Swiss pharmaceutical company, Mepha Pharma AGreported an error in the manufacture of the drug Atenolol-Mepha®, widely used by those suffering from high blood pressure and heart problems. As described on the website of the Swiss Federal Council, the immediate withdrawal from the market of the drug only concerns lot number X15124F pack of 25 mg Lactab® 100 and expiring in July 2026.
What to do
According to what was communicated by the manufacturer, the batch in question shows a lower quantity of the active ingredient atenolol. This represents a danger for those suffering from arterial hypertension, as the effect of the drug on the body is almost mild. Those who regularly use the drug Atenolol-Mepha®, also prescribed to protect the heart muscle from overexertion (angina pectoris in medical jargon), are invited by the Swiss pharmaceutical company itself to check the corresponding batch number and the expiry date indicated. If it concerns the medicine in question, it is advisable to consult your doctor before taking it. KEEP READING..
Where to contact for clarification
The doctor, based on the patient’s health conditions, may suggest a replacement therapy or propose to take the same drug without any consequences or even go to the pharmacy to request a change and a possible refund. In this regard, the authorities have made available two telephone numbers that correspond to the Customer care of the Swiss pharmaceutical company Mepha Pharma AG, respectively 0800 00 33 88 e 061 705 43 43. Alternatively, you can write to the email address [email protected] (specifying the subject) and receive useful information.